Based on Ly6C and CD64 gating in flow cytometry analysis, we determined that ALK1-Fc reduced the frequency of circulating Ly6ChiCD64+ monocytes in tumor-free mice, and produced a similar trend in the adjuvant setting (Figure 7, D and E, and Supplemental Figure 6C). This evidence concerns the gene ALK and neoplasm.